1 asset in Panhypopituitarism
Therapeutic assets addressing Panhypopituitarism, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Liraglutide Panhypopituitarism | Seoul National University Hospital | Early P1 | C (39) |